Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 110
Filter
Add more filters

Publication year range
1.
Pharmazie ; 76(6): 279-286, 2021 06 01.
Article in English | MEDLINE | ID: mdl-34078523

ABSTRACT

A high proportion of hospitalizations is attributable to the prevalence of adverse drug events. This retrospective study included outpatients and inpatients to determine the prevalence of adverse drug events and if polypharmacy increases it. The prevalence, classification, and causality of adverse drug events were assessed based on medical records, laboratory values, and other data. Multivariate analysis (multiple logistic regression analysis) was performed with the presence or absence of adverse drug events at the time of the visit as the dependent variable and items for which the P-value was <0.25 in the univariate analysis as independent variables. The prevalence of adverse drug events was 13.0%, 10.9%, and 16.0% among all patients, the outpatient group, and the inpatient group, respectively. Multivariate analysis showed that polypharmacy (≥5 drugs) significantly increased the risk of adverse drug events in all patients. The prevalence of adverse drug events significantly increased with each additional drug used. We expect that minimizing the number of medications through moderation of the number of prescription drugs and elimination of polypharmacy will reduce the number of outpatient visits and hospitalizations due to adverse drug events.


Subject(s)
Drug-Related Side Effects and Adverse Reactions , Outpatients , Drug-Related Side Effects and Adverse Reactions/epidemiology , Hospitalization , Humans , Polypharmacy , Prevalence , Retrospective Studies
2.
Pharmazie ; 76(9): 444-449, 2021 09 01.
Article in English | MEDLINE | ID: mdl-34481536

ABSTRACT

The use of azacitidine (AZA) has been known to lead to a high incidence of hematotoxic adverse events. The aims of this study were to identify the risk factors for thrombocytopenia after the administration of AZA and to analyze time to the initial platelet transfusion. Sixty-two patients with myelodysplastic syndrome (MDS), who were treated with AZA in Gifu Municipal Hospital between March 2012 and June 2020, were included in this study. The risk factors for thrombocytopenia were identified using univariate analysis of patient characteristics, disease type, and laboratory values immediately before the start of treatment. Variables with p<0.2 identified in the univariate analysis were used as independent variables in the multivariate analysis. This analysis identified "creatinine clearance (CCr) <60 mL/min" as a significant factor (odds ratio, 4.790; 95% confidence interval [CI], 1.380-16.70; p=0.014). Subsequently, time in days to the initial platelet transfusion after the initial administration of AZA was analyzed using the log-rank test. The overall median time in days to platelet transfusion was 370 days. The log-rank test was used to determine the influence of patient characteristics, disease type, and laboratory values immediately before the start of treatment. The subsequent Cox proportional hazard regression analysis using variables with p<0.2 as independent variables identified "hemoglobin (Hb) <8.0 g/dL" as a significant factor (hazard ratio, 2.143; 95% CI, 1.001-4.573; p=0.048). The results of this study led to the following clinical implications: first, patients with CCr of <60 mL/min at the start of treatment should be treated with caution due to the risk of thrombocytopenia. Second, patients with Hb of <8.0 g/dL at the start of treatment may require platelet transfusion in the early stage of treatment.


Subject(s)
Myelodysplastic Syndromes , Thrombocytopenia , Azacitidine/adverse effects , Humans , Myelodysplastic Syndromes/chemically induced , Myelodysplastic Syndromes/drug therapy , Platelet Transfusion/adverse effects , Risk Factors , Thrombocytopenia/chemically induced , Thrombocytopenia/drug therapy , Thrombocytopenia/epidemiology
3.
Pharmazie ; 74(6): 374-382, 2019 06 01.
Article in English | MEDLINE | ID: mdl-31138377

ABSTRACT

We retrospectively investigated the renal function index of patients with type 2 diabetes mellitus (T2DM) to examine the influence of dipeptidyl peptidase-4 (DPP-4) inhibitors on renal function between patients up to early nephropathy and after overt nephropathy. Patients with T2DM (>18 years old) who had been prescribed hypoglycemic agents for ≥3 months at Gifu Municipal Hospital between March 2010 and April 2014 were included in the study. Renal function was evaluated as the estimated glomerular filtration rate (eGFR) decline from baseline at 12 months. Patients in the DPP-4 inhibitor-treated and untreated groups with an eGFR ≥60 (358 [58.2 %] and 257 [41.8 %], respectively) and eGFR <60 (115 [60.2 %] and 76 [39.8 %], respectively) were subjected to multiple logistic regression analysis. Among patients with an eGFR ≥60, no significant differences were observed in eGFR decline rates over time. However, among patients with an eGFR <60, significant decreases were observed in eGFR decline rates >10 % (6 months; odds ratio, 0.476; P = 0.043, 12 months; odds ratio, 0.413; P = 0.010). Similar results were obtained for an eGFR decline rate >20 % (12 months; odds ratio, 0.369; P = 0.049). DPP-4 inhibitors are renoprotective in patients with T2DM and an eGFR <60.


Subject(s)
Dipeptidyl-Peptidase IV Inhibitors/pharmacology , Glomerular Filtration Rate/drug effects , Aged , Diabetes Mellitus, Type 2 , Dipeptidyl-Peptidase IV Inhibitors/therapeutic use , Female , Humans , Hypoglycemic Agents/pharmacology , Kidney Diseases , Male , Middle Aged , Retrospective Studies
4.
Pharmazie ; 68(12): 977-82, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24400446

ABSTRACT

Ensuring an appropriate dosage of renally eliminated drugs for patients with renal insufficiency is important for preventing adverse drug reactions. We investigated the effectiveness of interventions by pharmacists in a hospital pharmaceutical department. The comparative study was performed at Gifu Municipal Hospital in Japan from March to August 2011, and included an intervention (142 patients) and a control group (98 patients). Upon receiving a prescription of levofloxacin for patients aged > or = 75 years, pharmacists evaluated the patients' kidney function and adjusted the appropriate dosage at the time of dispensation. In the intervention and control groups, levofloxacin-induced adverse reactions developed in 6 of 142 (4.2%) and 13 of 98 (13.3%) patients, respectively (p < 0.05). The cost of reducing levofloxacin per patient was yen 191.1 and yen 0 in the intervention and control groups, respectively. The cost per patient for adverse reaction treatments and examinations was yen 15.5 and yen 290.0 in the intervention and control groups, respectively. The intergroup difference in the total cost per patient was yen 465.6. Dose adjustment of levofloxacin at the time of dispensation by the pharmacist for patients aged > or = 75 years resulted in a decrease in the incidence of adverse reactions and cost. These findings can be applied not only to hospitals, but also to community pharmacies, because the intervention, which is a manual system, is simply performed when pharmacists are dispensing drugs.


Subject(s)
Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/adverse effects , Levofloxacin/administration & dosage , Levofloxacin/adverse effects , Pharmacists , Aged , Aged, 80 and over , Anti-Bacterial Agents/therapeutic use , Cost Control , Drug Costs , Female , Humans , Levofloxacin/therapeutic use , Male , Medical Records , Pharmacy Service, Hospital
5.
Pharmazie ; 68(8): 706-10, 2013 Aug.
Article in English | MEDLINE | ID: mdl-24020129

ABSTRACT

Measures for prevention of Clostridium difficile-associated diarrhea, a common nosocomial infection, in hospital settings are urgently needed. This study was conducted to identify the risk factors contributing to C. difficile-associated diarrhea and to evaluate the clinical benefit of probiotics in its prevention. The study included 2716 patients at least 20 years old who received an injected antibiotic at any time between February 2010 and February 2011; a total of 2687 patients (98.9%) were assigned to the non-C. difficile-associated diarrhea group, and 29 patients (1.1%) were assigned to the C. difficile-associated diarrhea group. Univariate analysis revealed a significant difference between the two groups for the following factors: antibiotic therapy for > or = 8 days; enteral nutrition; intravenous hyperalimentation; fasting; proton pump inhibitor use; H2 blocker use; and serum albumin < or = 2.9g/dL (p<0.05). Multivariate logistic regression analysis revealed a significant difference between the two groups for several factors. Antibiotic therapy for > or = 8 days, intravenous hyperalimentation, proton pump inhibitor use, and H2 blocker use were therefore shown to be risk factors for C. difficile-associated diarrhea. Prophylactic probiotic therapy was not shown to suppress the occurrence of C. difficile-associated diarrhea.


Subject(s)
Clostridioides difficile , Diarrhea/epidemiology , Diarrhea/prevention & control , Enterocolitis, Pseudomembranous/epidemiology , Enterocolitis, Pseudomembranous/prevention & control , Probiotics/therapeutic use , Aged , Anti-Bacterial Agents/adverse effects , Cross Infection/prevention & control , Diarrhea/microbiology , Enteral Nutrition/adverse effects , Enterocolitis, Pseudomembranous/microbiology , Female , Histamine H2 Antagonists/adverse effects , Humans , Logistic Models , Male , Proton Pump Inhibitors/adverse effects , Retrospective Studies , Risk Factors
6.
Phys Rev Lett ; 107(13): 132502, 2011 Sep 23.
Article in English | MEDLINE | ID: mdl-22026847

ABSTRACT

The (2)H(d,p)(3)H, (2)H(d,n)(3)He, and (2)H(d,γ)(4)He reactions are studied at low energies in a multichannel ab initio model that takes into account the distortions of the nuclei. The internal wave functions of these nuclei are given by the stochastic variational method with the AV8' realistic interaction and a phenomenological three-body force included to reproduce the two-body thresholds. The obtained astrophysical S factors are all in very good agreement with the experiment. The most important channels for both transfer and radiative capture are identified by comparing to calculations with an effective central force. They are all found to dominate thanks to the tensor force.

7.
Arch Dis Child Fetal Neonatal Ed ; 92(2): F113-6, 2007 Mar.
Article in English | MEDLINE | ID: mdl-16905571

ABSTRACT

OBJECTIVE: To examine the auditory perception of maternal utterances by neonates using near-infrared spectroscopy (NIRS). METHODS: Twenty full-term, healthy neonates were included in this study. The neonates were tested in their cribs while they slept in a silent room. First, two probe holders were placed on the left and right sides of the forehead over the eyebrows using double-sided adhesive tape. The neonates were then exposed to auditory stimuli in the form of infant-directed speech (IDS) or adult-directed speech (ADS), sampled from each of the mothers, through an external auditory speaker. RESULTS: A 2 (stimulus: IDS and ADS) x 2 (recording site: channel 1 (right side) and channel 2 (left side)) analysis of variance for these relative oxygenated haemoglobin values showed that IDS (Mean = 0.25) increased brain function significantly (F = 3.51) more than ADS (Mean = -0.26). CONCLUSIONS: IDS significantly increased brain function compared with ADS. These results suggest that the emotional tone of maternal utterances could have a role in activating the brains of neonates to attend to the utterances, even while sleeping.


Subject(s)
Frontal Lobe/blood supply , Mother-Child Relations , Mothers/psychology , Speech Perception/physiology , Verbal Behavior , Acoustic Stimulation/methods , Cerebrovascular Circulation , Communication , Female , Humans , Infant, Newborn , Male , Oxyhemoglobins/metabolism
8.
Cancer Res ; 46(7): 3608-13, 1986 Jul.
Article in English | MEDLINE | ID: mdl-3011252

ABSTRACT

The fate of integrated woodchuck hepatitis viral (WHV) DNA was systematically investigated in DNA samples from primary hepatocellular carcinoma (HCC) of woodchucks, solid tumors transplanted in athymic mice derived from a primary HCC of woodchuck, and an established cell line of tissue culture originating from the transplanted tumor. In four of five woodchuck primary HCCs, WHV DNA integration was demonstrated in addition to various amounts of extrachromosomal replicative intermediate WHV DNA. The integration pattern of the primary HCCs does not indicate a common integration site on the host chromosome. The integration pattern in the established cells is identical to that in the transplanted tumor and similar but slightly different from that of the primary HCC. No extrachromosomal or replicative intermediates of WHV DNA were detected in the transplanted tumors or in the established cells of tissue culture. There are three integration sites on the chromosomes of the established cells. Results of Southern hybridization and restriction maps of cloned fragments suggest that all of these integrated WHV DNA sequences are not a complete genome but a part of the genome. A small portion corresponding to the cohesive region of the genome was not detected in all of these integrated WHV DNA. A positive role of WHV DNA integration on the generation of HCC is strongly suggested by the high incidence of WHV DNA integration in woodchuck primary HCCs and the stable maintenance of a certain mode of WHV DNA integration in the hepatoma-derived cell populations during passages of transplantation or serial growth of tissue culture.


Subject(s)
Cell Transformation, Viral , Hepatitis Viruses/genetics , Liver Neoplasms, Experimental/genetics , Marmota/microbiology , Sciuridae/microbiology , Animals , Cell Line , Chromosome Mapping , DNA Restriction Enzymes , DNA, Neoplasm/genetics , DNA, Viral/genetics , Neoplasm Transplantation
9.
FEBS Lett ; 242(1): 36-40, 1988 Dec 19.
Article in English | MEDLINE | ID: mdl-3060375

ABSTRACT

The lipase gene from Pseudomonas fragi IFO-12049 was isolated using the expression library and the primary structure of lipase deduced from the nucleotide sequence was determined. It is composed of 277 amino acid residues and a protein of Mr 29,966, which was close to the value of the lipase expressed in E. coli.


Subject(s)
Cloning, Molecular , Escherichia coli/genetics , Gene Expression Regulation , Lipase/genetics , Pseudomonas/genetics , Amino Acid Sequence , Base Sequence , Blotting, Southern , Chromosome Mapping , DNA, Bacterial/genetics , Molecular Sequence Data , Molecular Weight , Nucleic Acid Hybridization , Pseudomonas/enzymology
10.
Cytogenet Genome Res ; 101(3-4): 295-301, 2003.
Article in English | MEDLINE | ID: mdl-14684998

ABSTRACT

Many genes are known to be involved in gonadal differentiation in vertebrates. Dmrt1, a gene that encodes a transcription factor with a DM-domain, is considered to be one of the essential genes controlling testicular differentiation in mammals, birds, reptiles, amphibians and fish. However, it still remains unknown which testicular cells of animals other than mice and chicks express Dmrt1 protein. For an explanation of its role(s) in testicular differentiation in vertebrates, the expression of the Dmrt1 protein needs to be studied. For this purpose, we conducted an immunohistochemical study of this protein in an amphibian by using an antibody specific for Dmrt1. No positive signal was found in the indifferent gonad of tadpoles of Rana rugosa at early stages. However, in the testis of tadpoles at later stages (XV-XXV) and in frogs one month after metamorphosis, this protein was expressed in interstitial cells and Sertoli cells. In the testis of adult frogs, germ cells also expressed Dmrt1 protein. RT-PCR analysis revealed that the gene for this protein was not transcribed at any time during ovarian development, but was expressed in the female to male sex-reversed gonad. This was true when immunohistological studies were performed. In addition, Southern blot analysis showed DMRT1 to be an autosomal gene. Taken together, our findings indicate that Dmrt1 protein is expressed by interstitial cells, Seroli cells and germ cells in the testis of R. rugosa. Dmrt1 may thus be very involved in the testicular differentiation of amphibians.


Subject(s)
Hermaphroditic Organisms , Ranidae/growth & development , Sex Determination Processes , Testis/metabolism , Transcription Factors/metabolism , Animals , Female , Immunohistochemistry , In Situ Hybridization , Male , Ovary/metabolism , RNA, Messenger/analysis , Ranidae/genetics , Ranidae/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Testis/chemistry , Testis/growth & development , Transcription Factors/genetics , Transcription Factors/immunology , Transcription, Genetic
11.
J Med Chem ; 39(26): 5047-52, 1996 Dec 20.
Article in English | MEDLINE | ID: mdl-8978835

ABSTRACT

A series of indole derivatives with varied substituents on the alpha, beta-unsaturated double bond were synthesized and evaluated for their ability to inhibit rat prostatic 5 alpha-reductase. Compounds possessing an ethyl substituent at the beta-position of the double bond showed potent inhibitory activity. Among them, (Z)-4-{2-[[3-[1-(4,4'-difluorobenzhydryl)indol-5-yl]-2-pentenoy l]- amino]phenoxy}butyric acid (16, KF20405) showed the maximum potency with an IC50 value of 0.48 +/- 0.086 nM, which was 20-fold higher potency than 1 (MK-906). Compound 16 effectively inhibited DHT production 4 h after a 3 mg/kg oral administration. Several potent indole derivatives, 1 and 2 ((+/-)-ONO-3805), were tested versus rat and human isozymes. Nonsteroidal inhibitors such as indole derivatives and 2 were 2-3 orders of magnitude less potent for human type 2 isozyme than steroidal inhibitor 1 and expressed a significant species deference for these isozymes.


Subject(s)
5-alpha Reductase Inhibitors , Enzyme Inhibitors/pharmacology , Isoenzymes/antagonists & inhibitors , Animals , Enzyme Inhibitors/chemistry , Humans , Magnetic Resonance Spectroscopy , Male , Prostate/drug effects , Prostate/enzymology , Rats , Rats, Wistar
12.
Mol Cell Endocrinol ; 105(2): 147-54, 1994 Nov.
Article in English | MEDLINE | ID: mdl-7859921

ABSTRACT

We have generated transgenic mice that express the simian virus 40 (SV40) large T antigen under the control of a 1109 bp 5'-flanking sequence of the human thyrotropin beta-subunit (TSH beta) gene. The hybrid gene, termed TTP-1, was microinjected into fertilized mouse eggs and 11 transgenic mice were obtained. One of the transgenic mice, a female, a phenotypical dwarf, developed a pituitary tumor and wasted away from 7 to 9 weeks after birth. To establish the transgenic mouse line, her ovaries were transferred to a normal female, whose ovaries were removed beforehand. To examine the tissue specificity of transgene expression, mRNA of SV40 large T antigen was monitored in various tissues from the transgenic mice by the reverse transcriptase-polymerase chain reaction analysis, and was detected only in the pituitary. Histological and immunohistochemical analyses showed that the pituitary tumors of the transgenic mice were composed of poorly differentiated pituitary cells expressing SV40 large T antigen. These results indicated that the 1109 bp sequence of the human TSH beta 5'-flanking region is essential for pituitary-specific expression of SV40 large T antigen in transgenic mice, which exhibited a dwarf phenotype and developed pituitary tumors. The tumors were composed of undifferentiated cells and did not produce thyrotropin. These transgenic mice should provide a valuable animal model for studying the pathogenesis of anterior pituitary tumors.


Subject(s)
Pituitary Neoplasms/etiology , Pituitary Neoplasms/genetics , Promoter Regions, Genetic/genetics , Thyrotropin/genetics , Animals , Antigens, Polyomavirus Transforming/analysis , Antigens, Polyomavirus Transforming/genetics , Base Sequence , Cell Transformation, Neoplastic/genetics , Cell Transformation, Neoplastic/pathology , DNA Primers/analysis , DNA Primers/chemistry , DNA Primers/genetics , Disease Models, Animal , Female , Gene Expression Regulation, Neoplastic , Immunohistochemistry , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic , Molecular Sequence Data , Pituitary Gland, Anterior/chemistry , Pituitary Gland, Anterior/metabolism , Pituitary Gland, Anterior/pathology , Pituitary Neoplasms/immunology , Polymerase Chain Reaction , RNA, Messenger/analysis , RNA, Messenger/genetics , Thyrotropin/analysis
13.
J Biochem ; 105(3): 473-7, 1989 Mar.
Article in English | MEDLINE | ID: mdl-2567290

ABSTRACT

The small, monomeric Ca2+-binding photoprotein, aequorin, emits blue light by an intramolecular reaction when mixed with Ca2+. The photoprotein is made up of coelenterazine and molecular oxygen, bound noncovalently to apoaequorin (apoprotein). The chemical steps leading to light emission, involving the oxidative degradation of coelenterazine, have been studied extensively, but little is known about the active site and how the molecule catalyzes the oxidation of coelenterazine. The three-dimensional structure of the protein has not been determined and therefore answers to these questions have remained unavailable. The present paper describes a procedure for preparing fairly large amounts of apoaequorin and aequorin for X-ray crystallographic studies. It consists of fusing the apoaequorin cDNA to the signal peptide coding sequence of the outer membrane protein A of Escherichia coli, which is under the control of the lipoprotein promoter. When the cDNA was expressed in E. coli, a large excess of the recombinant protein was produced and released into the culture medium. Purification of the protein was accomplished by acid precipitation and DEAE-cellulose chromatography. The procedure yielded 7.4 mg of recombinant apoaequorin with a purity greater than 95% from 200 ml of culture medium. On regeneration with coelenterazine, the recombinant aequorin was fully active with Ca2+.


Subject(s)
Aequorin/biosynthesis , Apoproteins/biosynthesis , Calcium-Binding Proteins/biosynthesis , Cnidaria/metabolism , Gene Expression Regulation , Luminescent Proteins/biosynthesis , Scyphozoa/metabolism , Aequorin/genetics , Aequorin/isolation & purification , Amino Acids/analysis , Animals , Apoproteins/genetics , Apoproteins/isolation & purification , Calcium-Binding Proteins/genetics , Calcium-Binding Proteins/isolation & purification , Chromatography, DEAE-Cellulose , DNA, Bacterial/genetics , Electrophoresis, Polyacrylamide Gel , Escherichia coli/metabolism , Isoelectric Focusing , Luminescent Measurements , Molecular Weight , Plasmids , Recombinant Proteins/biosynthesis , Recombinant Proteins/genetics , Recombinant Proteins/isolation & purification
14.
Histol Histopathol ; 12(4): 981-90, 1997 Oct.
Article in English | MEDLINE | ID: mdl-9302559

ABSTRACT

We have created a transgenic mouse, TTP-1, generating anterior pituitary tumors by using the simian virus 40 (SV40) large T antigen gene and human thyrotropin beta-subunit gene. To examine characteristics of tumors, histological details were investigated using light and electron microscopies. The main tumor tissues, composed of small chromophobe cells, were located inferior to but clearly separated from the hypothalamus; however, neuron fibers probably derived from the hypothalamus were observed to invade some tumor tissues. Some differentiated endocrine cells occupied the caudal region of the tumor. Immunohistochemically, SV40 large T antigen was expressed in the cell nucleus of the undifferentiated cell area, whereas cells expressing several hormones were mainly distributed in the differentiated cell area. Electron microscopically, the undifferentiated cells were divided into 2 types; electron-dense and -lucent cells, the nuclei of which were composed of obscured nucleoli and many notable invaginations of the nuclear membrane. No intracellular microfilamentous structures were observed. Sometimes it was noted that cytoplasmic processes were connected with gap junctions. In the intercellular spaces, there were neuron fibrous and synapse-like structures. In the differentiated cell area, the cell membranes directly contacting other cells were relatively smooth, and many gap junctions were demonstrated. Secretory granules, which were round and less than 100 nm in diameter, were more electron dense in smaller cells than in larger cells. They were aligned just below the cell membrane. Immuno-electron microscopically, positive reactions for SV40 were observed in the nuclei of the undifferentiated cell area. In the differentiated cell area, most of the secretory granules were labeled by GH. TTP-1 transgenic mice should provide a valuable animal model for studying the pathogenesis of anterior pituitary tumors.


Subject(s)
Antigens, Polyomavirus Transforming/genetics , Antigens, Polyomavirus Transforming/metabolism , Oncogenes , Pituitary Neoplasms/genetics , Pituitary Neoplasms/pathology , Thyrotropin/genetics , Thyrotropin/metabolism , Animals , Cell Differentiation/physiology , Gap Junctions/ultrastructure , Immunohistochemistry , Mice , Mice, Inbred C57BL , Mice, Transgenic , Microscopy, Immunoelectron , Neurons/ultrastructure , Pituitary Gland, Anterior/pathology
15.
Avian Dis ; 23(1): 128-31, 1979.
Article in English | MEDLINE | ID: mdl-226050

ABSTRACT

Three Beaudette strains of infectious bronchitis virus (IBV) [two chicken-embryo trachea-culture-adapted (E71CET10 and E71CEK10CET30) and one embryo-adapted (E72)] were propagated in 10-day-old embryonated chicken eggs (CE) to investigate growth and lethality patterns. The E72 and E71CEK10CET30 viruses were similar in growth pattern as to logarithmic phase and maximum virus production, but 95% of the CE mortality with E72 virus occurred between 20 and 32 hours whereas with E71CEK10CET30 60% mortality occurred between 36 and 84 hours. The yield of the E71CET10 virus was minimum, with little lethality.


Subject(s)
Coronaviridae/pathogenicity , Infectious bronchitis virus/pathogenicity , Virus Replication , Animals , Chick Embryo , Eggs , Organ Culture Techniques
16.
Avian Dis ; 23(4): 983-8, 1979.
Article in English | MEDLINE | ID: mdl-546417

ABSTRACT

The effects of incubation temperature on virus growth and mortality patterns were studied in antibody-free chicken eggs inoculated with the B1 strain of Newcastle disease virus. Embryo mortality patterns did not differ much between 37, 39, and 41 C of incubation, although virus growth curves were higher at 39 C and 41 C than at 37 C. Below 35 C, embryo mortality was delayed, although from 48 hours after incubation the virus growth curves were similar to those at 37 C. In eggs with and without maternal antibody, virus titers were maximum 48 hours after incubation, although slightly higher in antibody-free eggs than in eggs with antibody whether the eggs were alive or dead. Eggs with maternal antibody had delayed mortality patterns.


Subject(s)
Antibodies, Viral/analysis , Chick Embryo/immunology , Immunity, Maternally-Acquired , Newcastle disease virus/growth & development , Temperature , Animals , Chick Embryo/microbiology , Chickens/immunology , Female , Newcastle disease virus/immunology
17.
Avian Dis ; 35(4): 659-61, 1991.
Article in English | MEDLINE | ID: mdl-1664717

ABSTRACT

Antibody response of recombinant fowlpox virus (FPV) was studied in chickens inoculated with the virus in the presence or absence of antibodies against Newcastle disease virus (NDV) or FPV. In the case of NDV, high hemagglutination-inhibition titers to NDV were obtained when the antibody was present. No immune response to NDV was observed in the chickens previously vaccinated with FPV.


Subject(s)
Antibodies, Viral/biosynthesis , Fowlpox virus/immunology , HN Protein/genetics , Newcastle disease virus/immunology , Viral Vaccines/immunology , Animals , Antibodies, Viral/immunology , Chickens , Fowlpox virus/genetics , Gene Expression Regulation, Viral , HN Protein/immunology , Hemagglutination Inhibition Tests , Newcastle Disease/prevention & control , Recombinant Proteins/genetics , Recombinant Proteins/immunology , Specific Pathogen-Free Organisms , Vaccination/veterinary , Vaccines, Synthetic/genetics , Vaccines, Synthetic/immunology , Viral Vaccines/genetics
18.
Avian Dis ; 29(2): 546-51, 1985.
Article in English | MEDLINE | ID: mdl-2992442

ABSTRACT

Five trials were conducted to compare four in vitro methods of isolating avian infectious bronchitis virus (IBV)-direct organ culture of infected tracheal rings (DOC), inoculation of tracheal organ culture (OC), inoculation of chicken embryo, and inoculation of cultured cells. DOC was prepared from tracheas of chickens experimentally inoculated with field samples. In the other methods, pooled tracheal and kidney suspensions were used to inoculate OC, chicken embryos, and cultured cells. IBV was consistently isolated at the initial passage by the DOC and OC inoculation systems, but it was not always isolated by embryo inoculation and never isolated by cultured-cell inoculation. When combined with immunofluorescent staining, DOC was much more efficient than the OC inoculation system for isolation and identification of the five strains of IBV tested because of its simplicity and speed.


Subject(s)
Chickens , Coronaviridae Infections/veterinary , Coronaviridae/isolation & purification , Infectious bronchitis virus/isolation & purification , Poultry Diseases/diagnosis , Respiratory Tract Infections/veterinary , Trachea/microbiology , Virus Cultivation/methods , Animals , Chick Embryo , Cytopathogenic Effect, Viral , Fluorescent Antibody Technique , Immunodiffusion/veterinary , Organ Culture Techniques
19.
Avian Dis ; 38(4): 772-7, 1994.
Article in English | MEDLINE | ID: mdl-7702510

ABSTRACT

The hybrid baculovirus constructed from Autographa california nuclear polyhedrosis virus (NPV) and Bombyx mori (silkworm) NPV was used for expression of fusion glycoprotein (F) of Newcastle disease virus (NDV) strain D26. The gene encoding F protein was introduced into the improved baculovirus expression vector derived from the host-range-expanded baculovirus. In Spodoptera frugiperda (fall armyworm) cells infected with a recombinant baculovirus, HyF121, the expressed F protein was properly located onto the cell surface. After silkworm pupae were infected with HyF121, a subunit vaccine against NDV was prepared from the HyF121-infected pupae. Chickens inoculated with the subunit vaccine were protected against virulent NDV challenge.


Subject(s)
Chickens , Gene Expression Regulation, Viral , Newcastle Disease/prevention & control , Newcastle disease virus/chemistry , Nucleopolyhedroviruses/chemistry , Viral Fusion Proteins/biosynthesis , Viral Vaccines , Animals , Newcastle Disease/immunology , Newcastle disease virus/genetics , Newcastle disease virus/immunology , Nucleopolyhedroviruses/genetics , Nucleopolyhedroviruses/immunology , Plasmids , Transfection , Viral Fusion Proteins/genetics , Viral Fusion Proteins/immunology , Viral Vaccines/immunology
20.
Intern Med ; 37(8): 694-9, 1998 Aug.
Article in English | MEDLINE | ID: mdl-9745858

ABSTRACT

A 50-year-old woman was treated with prednisolone for polymyositis. During the therapy, thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS) occurred. Neither plasma infusion nor plasma exchange could relieve the clinical manifestations of TTP/HUS. Moreover, massive ascites appeared and worsened her condition. She died approximately one year after the diagnosis of polymyositis. The autopsy revealed centri-lobular hepatic necrosis and nonthrombotic obliteration of hepatic small veins. The diagnosis of hepatic veno-occlusive disease (VOD) was made. It was suspected that common factors other than cytoreductive therapy had damaged the endothelium and caused TTP/HUS and VOD in a case of polymyositis.


Subject(s)
Hemolytic-Uremic Syndrome/complications , Hepatic Veno-Occlusive Disease/complications , Polymyositis/complications , Purpura, Thrombotic Thrombocytopenic/complications , Anti-Inflammatory Agents/adverse effects , Female , Hemolytic-Uremic Syndrome/etiology , Hemolytic-Uremic Syndrome/therapy , Hepatic Veno-Occlusive Disease/etiology , Hepatic Veno-Occlusive Disease/pathology , Humans , Middle Aged , Plasma Exchange , Polymyositis/drug therapy , Prednisolone/adverse effects , Purpura, Thrombotic Thrombocytopenic/etiology , Purpura, Thrombotic Thrombocytopenic/therapy
SELECTION OF CITATIONS
SEARCH DETAIL